Study Details

General Information

Kowa Lipids NK-104-CR-3.01US

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Pitavastatin CR 8 mg on the Reduction of LDL-C after 12 Weeks of Administration in Patients with Primary Hyperlipidemia or Mixed Dyslipidemia.

ProtocolNK-104-CR-3.01US
IdentifierNK-104-CR-3.01US Site No: 13
UID39b99611-d7d1-4263-bb04-d2680daa1e3a
StatusDone - Archived
Phase3
CategoryHigh Cholesterol / Adult
Launch Year2015
NCT Number-
Created2015-09-03 12:26
Last Updated2015-09-03 12:26

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2016-02-29No
Enrollment Open2016-02-08No
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting Start2016-02-03No
PI Meeting End2016-02-05No
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2016-04-27No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
Coordinator-No
Regulatory-No

Custom Fields

No custom fields.

Sponsor & Organization

SponsorKowa Research Institute, Inc.
DivisionKowa Research Institute
TeamKowa Research Institute
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROMedpace, Inc.
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?